Antiprogestin Testing Act of 1992
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Oct 5, 1992)
Antiprogestin Testing Act of 1992 - Directs the Secretary of Health and Human Services to conduct and support research, including clinical trials, on antiprogestin drug safety and efficacy for any potential use, including termination of pregnancy, contraception, and therapeutic use for cancer, endocrine disorders, and endometriosis. Makes the research subject to provisions relating to institutional review boards and peer review.
What just happenedNov 20, 1992
Referred to the Subcommittee on Health and the Environment.
Who’s behind it
- Nov 20, 1992CommitteeH11000
Referred to the Subcommittee on Health and the Environment.
Health and Environment Subcommittee - Oct 5, 1992IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Oct 5, 1992IntroReferralIntro-H
Introduced in House
- Oct 5, 1992IntroReferral1000
Introduced in House